Shuichi Nakatsuru
Comptroller/Controller/Auditor bij Immunas Pharma, Inc.
Vermogen: 631 976 $ op 30-04-2024
Profiel
Shuichi Nakatsuru is currently working as an Auditor at Immunas Pharma, Inc. since 2008.
Prior to this, he worked as the Director, VP & Head-Business Development at OncoTherapy Science, Inc. from 2007 to 2008.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2023 | 5 850 000 ( 2.62% ) | 631 976 $ | 30-04-2024 |
Actieve functies van Shuichi Nakatsuru
| Bedrijven | Functie | Begin |
|---|---|---|
Immunas Pharma, Inc.
 Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Comptroller/Controller/Auditor | 01-06-2008 |
Eerdere bekende functies van Shuichi Nakatsuru
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | President | 01-04-2003 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
